Ifosfamide - CAS 3778-73-2
Catalog number:
3778-73-2
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C7H15Cl2N2O2P
Molecular Weight:
261.09
COA:
Inquire
Targets:
DNA Alkylator/Crosslinker
Description:
Ifosfamide is a nitrogen mustard alkylating agent used in the treatment of cancer.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
Synonyms:
NSC109724, Isophosphamide
MSDS:
Inquire
1.Carcinosarcoma of the Lesser Omentum: A Unique Case Report and Literature Review.
Wang B1, Ren KW, Yang YC, Wan DL, Li XJ, Zhai ZL, Zhang LL, Zheng SS. Medicine (Baltimore). 2016 Apr;95(14):e3246. doi: 10.1097/MD.0000000000003246.
Carcinosarcoma is a rare tumor consisting of epithelial and mesenchymal components, both of which are histologically malignant. It usually runs an aggressive clinical course, with higher metastatic potential than other kinds of carcinomas or sarcomas.Here, we present an extremely uncommon case of carcinosarcoma occurred in the lesser omental bursa in a 65-year-old Chinese man. Metastasis was observed 2 months after operation and disappeared completely after chemotherapy. Until now, 3 years after surgery, the patient is still alive without any signs or symptoms of recurrence.To our knowledge, this is the first case of carcinosarcoma originated from lesser omentum. Surgical resection and the ifosfamide-based combination chemotherapy may be effective to carcinosarcoma in the lesser omentum.
2.Acute fibrinous and organising pneumonia: a rare histopathological variant of chemotherapy-induced lung injury.
Gupta A1, Sen S2, Naina H1. BMJ Case Rep. 2016 Apr 6;2016. pii: bcr2016214721. doi: 10.1136/bcr-2016-214721.
Bleomycin-induced lung injury is the most common chemotherapy-associated lung disease, and is linked with several histopathological patterns. Acute fibrinous and organising pneumonia (AFOP) is a relatively new and rare histological pattern of diffuse lung injury. We report the first known case of bleomycin-induced AFOP. A 36-year-old man with metastatic testicular cancer received three cycles of bleomycin, etoposide and cisplatin, before being transitioned to paclitaxel, ifosfamide and cisplatin. He subsequently presented with exertional dyspnoea, cough and pleuritic chest pain. CT of the chest demonstrated bilateral ground glass opacities with peribronchovascular distribution and pulmonary function tests demonstrated a restrictive pattern of lung disease with impaired diffusion. Transbronchial biopsy revealed intra-alveolar fibrin deposits with organising pneumonia, consisting of intraluminal loose connective tissue consistent with AFOP.
3.Risk-Stratified Initial Salvage Therapy for Relapsed or Refractory Metastatic Germ Cell Tumors.
Narayan V1, Gunnarsson O1, Hwang WT2, Squillante CM1, Nathanson KL1, Stadtmauer EA1, Vaughn DJ3. Clin Genitourin Cancer. 2016 Mar 24. pii: S1558-7673(16)30069-6. doi: 10.1016/j.clgc.2016.03.015. [Epub ahead of print]
BACKGROUND: Salvage treatment with either conventional-dose chemotherapy (CDCT) or high-dose chemotherapy with autologous stem cell transplantation (HDCT) offers curative potential for patients with relapsed or refractory germ cell tumor (GCT). However, the optimal initial salvage strategy remains controversial, and the criteria for appropriate patient selection are not clear.
4.An unresectable retroperitoneal malignant fibrous histiocytoma: A case report.
Hsiao PJ1, Chen GH1, Chang YH1, Chang CH1, Chang H2, Bai LY3. Oncol Lett. 2016 Apr;11(4):2403-2407. Epub 2016 Feb 25.
Malignant fibrous histiocytoma (MFH) is most commonly observed in the extremities and the trunk but rarely in retroperitoneum. The present case report documents a 64-year-old man who was admitted with an abdominal palpable mass for 6 months. After a thorough investigation, a tumor of the retroperitoneum was identified adhered to adjacent organs and vessels. The patient experienced mild hydronephrosis and hydroureter as a result of the tumor compression. A number of previous surgeons considered the tumor unresectable and suggested palliative treatment. En bloc resection of the tumor was attempted but incomplete surgery was performed initially as the tumor was friable and prone to bleeding. Therefore, a biopsy of the tumor was performed and a double J ureteral stent was set for hydronephrosis. Histopathological examination confirmed the tumor was an MFH. The patient received neo-adjuvant chemotherapy with 4 cycles of mesna, doxorubicin, ifosfamide, and dacarbazine (MAID).
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related DNA Alkylator/Crosslinker Products


CAS 154-93-8 Carmustine

Carmustine
(CAS: 154-93-8)

Carmustine is  antineoplastic nitrosourea. Carmustine alkylates and cross-links DNA during all phases of the cell cycle, resulting in disruption of DNA fun...

CAS 299-75-2 Treosulfan

Treosulfan
(CAS: 299-75-2)

Treosulfan is the prodrug of a bifunctional sulfonate alkylating agent with myeloablative, immunosuppresive, and antineoplastic activities. Under physiological ...

CAS 31645-39-3 Palifosfamide

Palifosfamide
(CAS: 31645-39-3)

Palifosfamide is a synthetic mustard compound with potential antineoplastic activity. An active metabolite of ifosfamide covalently linked to the amino acid lys...

CAS 232931-57-6 SJG-136

SJG-136
(CAS: 232931-57-6)

SJG136 is a pyrrolobenzodiazepine dimer with potential antineoplastic activity. SJG-136 binds to the minor groove of DNA and induces interstrand cross-links bet...

CAS 15663-27-1 Cisplatin

Cisplatin
(CAS: 15663-27-1)

Cisplatin induces cytotoxic by interaction with DNA to form DNA adducts which activate several signal transduction pathways, including Erk, p53, p73, and MAPK, ...

CAS 92118-27-9 Fotemustine

Fotemustine
(CAS: 92118-27-9)

Fotemustine is a chloroethylating nitrosourea with antineoplastic activity. Fotemustine alkylates guanine by forming chloroethyl adducts at the 6 position of gu...

Altretamine hydrochloride
(CAS: 2975-00-0)

Altretamine hydrochloride, also called as hexamethylmelamine hydrochloride, is an alkylating agent with apparently less toxicity compared to other cytotoxic dru...

CAS 50-18-0 Cyclophosphamide

Cyclophosphamide
(CAS: 50-18-0)

Low-dose preferentially deplets Treg cells; An alkylating agent of the nitrogen mustard type with antineoplastic and immunosuppressive activities; Phase I–II

CAS 41575-94-4 Carboplatin

Carboplatin
(CAS: 41575-94-4)

Carboplatin is a DNA synthesis inhibitor by binding to DNA and interfering with the cell's repair mechanism.

CAS 61825-94-3 Oxaliplatin

Oxaliplatin
(CAS: 61825-94-3)

Oxaliplatin is a platinum-based antineoplastic agent used in cancer chemotherapy that inhibits DNA synthesis by conforming DNA adducts in cancer cells.

CAS 23261-20-3 VAL-083

VAL-083
(CAS: 23261-20-3)

VAL-083 is a bi-functional alkylating agent; inhibit U251 and SF188 cell growth in monolayer better than TMZ and caused apoptosis.

CAS 55-98-1 Busulfan

Busulfan
(CAS: 55-98-1)

Busulfan is a cell cycle non-specific alkylating antineoplastic agent.

CAS 13010-47-4 Lomustine

Lomustine
(CAS: 13010-47-4)

Lomustine (420 μM) triggers apoptosis through the mitochondrial pathway via decrease in the level of the anti-apoptosis proteins Bcl-2 and Bcl-xl, respectively.

CAS 85622-93-1 Temozolomide

Temozolomide
(CAS: 85622-93-1)

Temozolomide is an oral chemotherapy drug.The therapeutic benefit of temozolomide depends on its ability to alkylate/methylate DNA, which most often occurs at t...

CAS 645-05-6 Altretamine

Altretamine
(CAS: 645-05-6)

Altretamine is an anti-neoplastic agent.

CAS 3778-73-2 Ifosfamide

Ifosfamide
(CAS: 3778-73-2)

Ifosfamide is a nitrogen mustard alkylating agent used in the treatment of cancer.

CAS 129580-63-8 Satraplatin

Satraplatin
(CAS: 129580-63-8)

Satraplatin, also known as JM216, is a platinum compound that is currently under investigation as one treatment of patients with advanced prostate cancer who ha...

CAS 18883-66-4 Streptozotocin

Streptozotocin
(CAS: 18883-66-4)

Streptozotocin is a glucosamine-nitrosourea derivative, which is a methylating, carcinogenic, antibiotic and diabetes inducing agent. It is commonly used for th...

Cgp 6809
(CAS: 84069-38-5)

Cgp 6809 is a new methylnitrosoureido-sugar derivative. It is active against a broad spectrum of transplantable tumours in mice and rats. But Phase I clinical t...

Chemical Structure

CAS 3778-73-2 Ifosfamide

Quick Inquiry

Verification code

Featured Items